Literature DB >> 27990572

Creation of a novel risk score for surgical site infection and occurrence after ventral hernia repair.

K E Poruk1, C W Hicks1, J Trent Magruder1, N Rodriguez-Unda2, K K Burce1, S C Azoury1, P Cornell1, C M Cooney1, F E Eckhauser3.   

Abstract

BACKGROUND: Complex ventral hernia repair (VHR) is a common surgical operation but carries a risk of complications from surgical site infections (SSI) and occurrences (SSO). We aimed to create a predictive risk score to identify patients at increased risk for SSO or SSI within 30 days of surgery.
METHODS: Data were prospectively collected on all patients undergoing VHR between January 2008 and February 2015 by a single surgeon. Multivariable logistic regression was used to identify independent factors predictive of SSO and SSI. Significant predictors of SSO and SSI were assigned point values based on their odds ratios to create a novel risk score, the Hopkins ventral hernia repair SSO/SSI risk score; predicted and actual rates of outcomes were then compared using weighted regression.
RESULTS: During the study period, 362 patients underwent open VHR. Thirty-day SSO and SSI occurred in 18.5 and 10% of patients, respectively. After risk adjustment, ASA class ≥3 (1 point), operative time ≥4 h (2 points), and the absence of a postoperative wound vacuum dressing (1 point) were predictive of 30-day SSO. Predicted risk of SSO utilizing this scoring system was 9.7, 19.4, 29.1, and 38.8% for 1, 2, 3, and 4 points (AUC = 0.73). For SSI, operative time ≥4 h (1 point) and the lack of a wound vacuum dressing (1 point) were predictive. Predicted risk of SSI based on this scoring system was 12.5% for 1 point and 25% for 2 points (AUC = 0.71). Actual vs. predicted rates of SSO and SSI correlated strongly for risk model with a coefficient of determination (R 2) of 0.92 and 0.91, respectively.
CONCLUSION: The novel Hopkins ventral hernia repair risk score accurately predicts risk of SSO and SSI after complex VHR. Further studies using a prospective randomized controlled trial will be needed to further validate our findings.

Entities:  

Keywords:  Risk score; SSI; SSO; Surgical site infection; Surgical site occurrence; VHR; Ventral hernia repair

Mesh:

Year:  2016        PMID: 27990572     DOI: 10.1007/s10029-016-1547-x

Source DB:  PubMed          Journal:  Hernia        ISSN: 1248-9204            Impact factor:   4.739


  15 in total

1.  Guideline for prevention of surgical site infection, 1999. Hospital Infection Control Practices Advisory Committee.

Authors:  A J Mangram; T C Horan; M L Pearson; L C Silver; W R Jarvis
Journal:  Infect Control Hosp Epidemiol       Date:  1999-04       Impact factor: 3.254

Review 2.  Incidence and prevention of ventral incisional hernia.

Authors:  R Le Huu Nho; D Mege; M Ouaïssi; I Sielezneff; B Sastre
Journal:  J Visc Surg       Date:  2012-11-09       Impact factor: 2.043

3.  Novel wound management system reduction of surgical site morbidity after ventral hernia repairs: a critical analysis.

Authors:  Kevin C Soares; Pablo A Baltodano; Caitlin W Hicks; Carisa M Cooney; Israel O Olorundare; Peter Cornell; Karen Burce; Frederic E Eckhauser
Journal:  Am J Surg       Date:  2014-08-07       Impact factor: 2.565

4.  Development and validation of a risk-stratification score for surgical site occurrence and surgical site infection after open ventral hernia repair.

Authors:  Rachel L Berger; Linda T Li; Stephanie C Hicks; Jessica A Davila; Lillian S Kao; Mike K Liang
Journal:  J Am Coll Surg       Date:  2013-09-17       Impact factor: 6.113

5.  Incidence of incisional hernia following emergency abdominal surgery.

Authors:  A Mingoli; A Puggioni; G Sgarzini; G Luciani; F Corzani; F Ciccarone; E Baldassarre; C Modini
Journal:  Ital J Gastroenterol Hepatol       Date:  1999 Aug-Sep

6.  Incisional ventral hernias: review of the literature and recommendations regarding the grading and technique of repair.

Authors:  Karl Breuing; Charles E Butler; Stephen Ferzoco; Michael Franz; Charles S Hultman; Joshua F Kilbridge; Michael Rosen; Ronald P Silverman; Daniel Vargo
Journal:  Surgery       Date:  2010-03-20       Impact factor: 3.982

7.  Predictors of wound infection in ventral hernia repair.

Authors:  Kelly R Finan; Catherine C Vick; Catarina I Kiefe; Leigh Neumayer; Mary T Hawn
Journal:  Am J Surg       Date:  2005-11       Impact factor: 2.565

8.  Factors affecting wound complications in repair of ventral hernias.

Authors:  T J White; M C Santos; J S Thompson
Journal:  Am Surg       Date:  1998-03       Impact factor: 0.688

Review 9.  Mesh-related infections after hernia repair surgery.

Authors:  M E Falagas; S K Kasiakou
Journal:  Clin Microbiol Infect       Date:  2005-01       Impact factor: 8.067

Review 10.  Open surgical procedures for incisional hernias.

Authors:  Dennis den Hartog; Alphons H M Dur; Wim E Tuinebreijer; Robert W Kreis
Journal:  Cochrane Database Syst Rev       Date:  2008-07-16
View more
  3 in total

1.  Definitions for Loss of Domain: An International Delphi Consensus of Expert Surgeons.

Authors:  Samuel G Parker; Steve Halligan; Mike K Liang; Filip E Muysoms; Gina L Adrales; Adam Boutall; Andrew C de Beaux; Ulrich A Dietz; Celia M Divino; Mary T Hawn; Todd B Heniford; Joon P Hong; Nabeel Ibrahim; Kamal M F Itani; Lars N Jorgensen; Agneta Montgomery; Salvador Morales-Conde; Yohann Renard; David L Sanders; Neil J Smart; Jared J Torkington; Alastair C J Windsor
Journal:  World J Surg       Date:  2020-04       Impact factor: 3.352

2.  Operative time tracking for umbilical hernia patients.

Authors:  Elisabeth M O Coffin; Dana Poloni; Pamela Burgess
Journal:  Surg Endosc       Date:  2022-09-06       Impact factor: 3.453

3.  Increased incidence of surgical site infection with a body mass index ≥ 35 kg/m2 following abdominal wall reconstruction with open component separation.

Authors:  Salvatore Docimo; Konstantinos Spaniolas; Michael Svestka; Andrew T Bates; Samer Sbayi; Jessica Schnur; Mark Talamini; Aurora D Pryor
Journal:  Surg Endosc       Date:  2018-10-22       Impact factor: 4.584

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.